atrial fibrillation vs flutter - HEALTHY
Nature: Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study TCTMD: Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter RESTORE SR to study efficacy and safety of vanoxerine in atrial fibrillation (AF) and atrial flutter (AFL) patients, results expected in the second half of 2016 LA JOLLA, Calif., Laguna ... Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter Yahoo Finance: Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities There is conflicting evidence regarding bisphosphonates and atrial fibrillation (AF) risk in osteoporosis patients. However, bisphosphonates are used in much higher doses in treatment of bone ...
Context Explanation
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ... Q: I’m a 67-year-old man who developed typical atrial flutter two years ago, but I haven’t had any symptoms that I am aware of. I don’t have a history of heart problems. My heart rate was 117 bpm ...